Form 8-K - Current report:
SEC Accession No. 0001437749-25-007742
Filing Date
2025-03-14
Accepted
2025-03-14 16:28:06
Documents
15
Period of Report
2025-03-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K veru20250314_8k.htm   iXBRL 8-K 51864
2 EXHIBIT 10.1 ex_790436.htm EX-10.1 163525
  Complete submission text file 0001437749-25-007742.txt   392982

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA veru-20250313.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE veru-20250313_def.xml EX-101.DEF 11807
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE veru-20250313_lab.xml EX-101.LAB 15858
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE veru-20250313_pre.xml EX-101.PRE 12022
17 EXTRACTED XBRL INSTANCE DOCUMENT veru20250314_8k_htm.xml XML 2933
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

EIN.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-13602 | Film No.: 25740416
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)